{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:52:20Z","timestamp":1788385940416,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS097313"],"award-info":[{"award-number":["R01NS097313"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010174","name":"University of Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG028271"],"award-info":[{"award-number":["R01AG028271"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbr.2020.112896","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T06:39:54Z","timestamp":1599374394000},"page":"112896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2\/TLR4 antagonist (+)-naltrexone"],"prefix":"10.1016","volume":"396","author":[{"given":"Andrew J.","family":"Kwilasz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel S.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julissa C.","family":"Duran-Malle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk E.W.","family":"Schrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Mitten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison A.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Litwiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda R.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Barrientos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2020.112896_bib0005","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2020.112896_bib0010","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bbr.2020.112896_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1025621700003","article-title":"Neuropsychological aspects of multiple sclerosis","volume":"8","author":"Brassington","year":"1998","journal-title":"Neuropsychol. Rev."},{"issue":"Suppl 200","key":"10.1016\/j.bbr.2020.112896_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ane.12656","article-title":"Immunomodulatory treatments and cognition in MS","volume":"134","author":"M\u00fcckschel","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbr.2020.112896_bib0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000004977","article-title":"Cognition in multiple sclerosis: state of the field and priorities for the future","volume":"90","author":"Sumowski","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2020.112896_bib0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nature11337","article-title":"T cells become licensed in the lung to enter the central nervous system","volume":"488","author":"Odoardi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2020.112896_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/208093","article-title":"Role of microglia in CNS autoimmunity","volume":"2013","author":"Goldmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bbr.2020.112896_bib0040","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bbr.2020.112896_bib0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/labinvest.3780235","article-title":"Multiple sclerosis: current pathophysiological concepts","volume":"81","author":"Wingerchuk","year":"2001","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.bbr.2020.112896_bib0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuroscience.2015.03.007","article-title":"Neuroinflammation in the normal aging hippocampus","volume":"309","author":"Barrientos","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2020.112896_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2019.01.002","article-title":"Neuroinflammation in mild cognitive impairment and Alzheimer\u2019s disease: a meta-analysis","volume":"50","author":"Bradburn","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbr.2020.112896_bib0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11920-009-0082-1","article-title":"Neuroinflammation and cognitive aging","volume":"12","author":"Ownby","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.bbr.2020.112896_bib0065","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbr.2020.112896_bib0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1352458508096684","article-title":"Cognitive impairment in multiple sclerosis","volume":"15","author":"Patti","year":"2009","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"key":"10.1016\/j.bbr.2020.112896_bib0075","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/1352458513480251","article-title":"A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis","volume":"19","author":"Ruet","year":"2013","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"key":"10.1016\/j.bbr.2020.112896_bib0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbi.2013.07.003","article-title":"Altered cognitive-emotional behavior in early experimental autoimmune encephalitis--cytokine and hormonal correlates","volume":"33","author":"Acharjee","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2020.112896_bib0085","doi-asserted-by":"crossref","first-page":"577163","DOI":"10.1016\/j.jneuroim.2020.577163","article-title":"Enhanced cognitive performance in experimental autoimmune encephalomyelitis mice treated with dimethyl fumarate after the appearance of disease symptoms","volume":"340","author":"das Neves","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2020.112896_bib0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.pbb.2012.11.010","article-title":"Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis","volume":"103","author":"Dayger","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2020.112896_bib0095","doi-asserted-by":"crossref","first-page":"20926","DOI":"10.1038\/srep20926","article-title":"Persistent activation of microglia and NADPH oxidase [corrected] drive hippocampal dysfunction in experimental multiple sclerosis","volume":"6","author":"Di Filippo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2020.112896_bib0100","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1073\/pnas.0500073102","article-title":"Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats","volume":"102","author":"D\u2019Intino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbr.2020.112896_bib0105","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.cell.2015.11.023","article-title":"Neuroinflammatory TNF\u03b1 impairs memory via astrocyte signaling","volume":"163","author":"Habbas","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2020.112896_bib0110","doi-asserted-by":"crossref","first-page":"e35476","DOI":"10.1371\/journal.pone.0035476","article-title":"Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2020.112896_bib0115","first-page":"255","article-title":"Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration","volume":"31","author":"Mandolesi","year":"2010","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.bbr.2020.112896_bib0120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbi.2016.11.010","article-title":"Selective dentate gyrus disruption causes memory impairment at the early stage of experimental multiple sclerosis","volume":"60","author":"Planche","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2020.112896_bib0125","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1073\/pnas.1209934109","article-title":"Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis","volume":"109","author":"Rahn","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2020.112896_bib0130","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/labinvest.2010.6","article-title":"Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE","volume":"90","author":"Ziehn","year":"2010","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.bbr.2020.112896_bib0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nbd.2013.02.007","article-title":"The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes","volume":"54","author":"Dutra","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2020.112896_bib0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuroscience.2017.01.016","article-title":"Regular exercise promotes memory function and enhances hippocampal neuroplasticity in experimental autoimmune encephalomyelitis mice","volume":"346","author":"Kim","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2020.112896_bib0145","doi-asserted-by":"crossref","first-page":"14235","DOI":"10.1038\/srep14235","article-title":"LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice","volume":"5","author":"Sun","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2020.112896_bib0150","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jnen\/61.11.1013","article-title":"Broad expression of Toll-like receptors in the human central nervous system","volume":"61","author":"Bsibsi","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbr.2020.112896_bib0155","doi-asserted-by":"crossref","first-page":"13064","DOI":"10.1073\/pnas.1120585109","article-title":"Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation","volume":"109","author":"Reynolds","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2020.112896_bib0160","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3389\/fimmu.2017.02012","article-title":"NLR-dependent regulation of inflammation in multiple sclerosis- dependent regulation of inflammation in multiple sclerosis","volume":"8","author":"Gharagozloo","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2020.112896_bib0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3621","article-title":"Pathological pain and the neuroimmune interface","volume":"14","author":"Grace","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbr.2020.112896_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: A promising therapeutic target for autoimmune diseases","author":"Shen","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbr.2020.112896_bib0175","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2020.112896_bib0180","first-page":"230","article-title":"The toll-like receptor 2 (TLR2)-related immunopathological responses in the multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"18","author":"Jafarzadeh","year":"2019","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.bbr.2020.112896_bib0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/09540261.2017.1322555","article-title":"Depression in multiple sclerosis","volume":"29","author":"Patten","year":"2017","journal-title":"Int. Rev. Psychiatry Abingdon Engl."},{"key":"10.1016\/j.bbr.2020.112896_bib0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbr.2020.112896_bib0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jpain.2013.12.007","article-title":"Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain","volume":"15","author":"Ellis","year":"2014","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.bbr.2020.112896_bib0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","article-title":"Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)","volume":"28","author":"Hutchinson","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112896_bib0205","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1021\/acs.jmedchem.5b00426","article-title":"Structure-Activity relationships of (+)-Naltrexone-Inspired Toll-like receptor 4 (TLR4) antagonists","volume":"58","author":"Selfridge","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbr.2020.112896_bib0210","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.biopsych.2012.12.019","article-title":"Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-Naltrexone on incubation of heroin craving","volume":"73","author":"Theberge","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112896_bib0215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-5728(03)00031-6","article-title":"Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE","volume":"136","author":"Ledeboer","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2020.112896_bib0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbi.2016.05.012","article-title":"Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy","volume":"59","author":"Grace","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2020.112896_bib0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbi.2015.01.014","article-title":"Adenosine 2A receptor agonism: a single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats","volume":"46","author":"Loram","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2020.112896_bib0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbi.2008.09.004","article-title":"Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy","volume":"23","author":"Sloane","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2020.112896_bib0235","series-title":"Neurobiology of Learning and Memory","author":"Rudy","year":"2014"},{"key":"10.1016\/j.bbr.2020.112896_bib0240","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.neuroimage.2008.05.038","article-title":"Mapping the brain pathways of declarative verbal memory: evidence from white matter lesions in the living human brain","volume":"42","author":"Sepulcre","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.bbr.2020.112896_bib0245","doi-asserted-by":"crossref","first-page":"14641","DOI":"10.1523\/JNEUROSCI.2173-12.2012","article-title":"Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats","volume":"32","author":"Barrientos","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.bbr.2020.112896_bib0250","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1585183","article-title":"Modality-specific retrograde amnesia of fear","volume":"256","author":"Kim","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbr.2020.112896_bib0255","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2020.112896_bib0260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbr.2020.112896_bib0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-019-1579-0","article-title":"TLR4-RelA-miR-30a signal pathway regulates Th17 differentiation during experimental autoimmune encephalomyelitis development","volume":"16","author":"Qu","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbr.2020.112896_bib0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2015.03.003","article-title":"Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-\u03baB1","volume":"165","author":"Park","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbr.2020.112896_bib0275","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11481-019-09854-1","article-title":"Toll-like receptor 4 promotes Th17 lymphocyte infiltration via CCL25\/CCR9 in pathogenesis of experimental autoimmune encephalomyelitis","volume":"14","author":"Zhang","year":"2019","journal-title":"J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol."},{"key":"10.1016\/j.bbr.2020.112896_bib0280","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1523\/JNEUROSCI.1598-03.2004","article-title":"The role of the dorsal hippocampus in the acquisition and retrieval of context memory representations","volume":"24","author":"Matus-Amat","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.bbr.2020.112896_bib0285","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1038\/s41598-019-43217-3","article-title":"High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning\/memory in C57BL\/6 mice","volume":"9","author":"Dos Santos","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2020.112896_bib0290","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuroscience.2015.03.008","article-title":"Hippocampal function is compromised in an animal model of multiple sclerosis","volume":"309","author":"Novkovic","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2020.112896_bib0295","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1007\/s12035-018-1049-1","article-title":"Beneficial effects of the calcium channel blocker CTK 01512-2 in a mouse model of multiple sclerosis","volume":"55","author":"Silva","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2020.112896_bib0300","doi-asserted-by":"crossref","first-page":"e54666","DOI":"10.1371\/journal.pone.0054666","article-title":"Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis","volume":"8","author":"Nistic\u00f2","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2020.112896_bib0305","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-019-01980-7","article-title":"The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"137","author":"Brambilla","year":"2019","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.bbr.2020.112896_bib0310","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0239-18.2018","article-title":"A functionally defined in vivo astrocyte population identified by c-Fos activation in a mouse model of multiple sclerosis modulated by S1P signaling: immediate-early astrocytes (ieAstrocytes)","volume":"5","author":"Groves","year":"2018","journal-title":"ENeuro"},{"key":"10.1016\/j.bbr.2020.112896_bib0315","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2020.112896_bib0320","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","article-title":"Microglial control of astrocytes in response to microbial metabolites","volume":"557","author":"Rothhammer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2020.112896_bib0325","doi-asserted-by":"crossref","first-page":"e0135898","DOI":"10.1371\/journal.pone.0135898","article-title":"Microglia Induce Neurotoxic IL-17+ \u03b3\u03b4 T Cells Dependent on TLR2, TLR4, and TLR9 Activation","volume":"10","author":"Derkow","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2020.112896_bib0330","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00462","article-title":"The anti-neuroinflammatory activity of tectorigenin pretreatment via downregulated NF-\u03baB and ERK\/JNK pathways in BV-2 microglial and microglia inactivation in mice with lipopolysaccharide","volume":"9","author":"Lim","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112896_bib0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2019.04.020","article-title":"Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE)","volume":"102","author":"Liu","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbr.2020.112896_bib0340","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.intimp.2018.08.034","article-title":"Melatonin mediated Foxp3-downregulation decreases cytokines production via the TLR2 and TLR4 pathways in H. pylori infected mice","volume":"64","author":"Luo","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbr.2020.112896_bib0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2012.02.003","article-title":"Luteolin downregulates TLR4, TLR5, NF-\u03baB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia","volume":"1448","author":"Qiao","year":"2012","journal-title":"Brain Res."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820305957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820305957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:22:56Z","timestamp":1759065776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432820305957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":69,"alternative-id":["S0166432820305957"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112896","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2\/TLR4 antagonist (+)-naltrexone","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112896"}}